These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9559808)
1. Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Wang QM; Johnson RB; Jungheim LN; Cohen JD; Villarreal EC Antimicrob Agents Chemother; 1998 Apr; 42(4):916-20. PubMed ID: 9559808 [TBL] [Abstract][Full Text] [Related]
2. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742 [TBL] [Abstract][Full Text] [Related]
3. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114 [TBL] [Abstract][Full Text] [Related]
4. Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Wanga QM; Chen SH Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. Zhang Q; Cao R; Liu A; Lei S; Li Y; Yang J; Li S; Xiao J Bioorg Med Chem Lett; 2017 Sep; 27(17):4061-4065. PubMed ID: 28778471 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947 [TBL] [Abstract][Full Text] [Related]
8. RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups. Croft SN; Walker EJ; Ghildyal R Viruses; 2021 Nov; 13(12):. PubMed ID: 34960671 [TBL] [Abstract][Full Text] [Related]
9. Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. Dragovich PS; Webber SE; Prins TJ; Zhou R; Marakovits JT; Tikhe JG; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Brown EL; Binford SL; Meador JW; Ferre RA; Worland ST Bioorg Med Chem Lett; 1999 Aug; 9(15):2189-94. PubMed ID: 10465543 [TBL] [Abstract][Full Text] [Related]
10. Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold. Tsilimingkra NT; Papaneophytou C Curr Top Med Chem; 2024; 24(15):1343-1358. PubMed ID: 38698747 [TBL] [Abstract][Full Text] [Related]
11. Rhinovirus 16 2A Protease Affects Nuclear Localization of 3CD during Infection. Walker E; Jensen L; Croft S; Wei K; Fulcher AJ; Jans DA; Ghildyal R J Virol; 2016 Dec; 90(24):11032-11042. PubMed ID: 27681132 [TBL] [Abstract][Full Text] [Related]
12. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro. Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517 [TBL] [Abstract][Full Text] [Related]
13. Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases. Heinz BA; Tang J; Labus JM; Chadwell FW; Kaldor SW; Hammond M Antimicrob Agents Chemother; 1996 Jan; 40(1):267-70. PubMed ID: 8787922 [TBL] [Abstract][Full Text] [Related]
14. Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Wang QM; Johnson RB; Sommergruber W; Shepherd TA Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985 [TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. Wang QM Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129 [TBL] [Abstract][Full Text] [Related]
16. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Patick AK; Brothers MA; Maldonado F; Binford S; Maldonado O; Fuhrman S; Petersen A; Smith GJ; Zalman LS; Burns-Naas LA; Tran JQ Antimicrob Agents Chemother; 2005 Jun; 49(6):2267-75. PubMed ID: 15917520 [TBL] [Abstract][Full Text] [Related]
17. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Wang QM; Johnson RB; Cox GA; Villarreal EC; Loncharich RJ Anal Biochem; 1997 Oct; 252(2):238-45. PubMed ID: 9344409 [TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. Wang QM Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209 [TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. Dragovich PS; Prins TJ; Zhou R; Brown EL; Maldonado FC; Fuhrman SA; Zalman LS; Tuntland T; Lee CA; Patick AK; Matthews DA; Hendrickson TF; Kosa MB; Liu B; Batugo MR; Gleeson JP; Sakata SK; Chen L; Guzman MC; Meador JW; Ferre RA; Worland ST J Med Chem; 2002 Apr; 45(8):1607-23. PubMed ID: 11931615 [TBL] [Abstract][Full Text] [Related]
20. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]